GENINUS Inc. (KOSDAQ:389030)
South Korea · Delayed Price · Currency is KRW 1,416.00
-27.00 (-1.87%)
At close: Oct 23, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 55.78 billion as of October 23, 2026. It is the 31,334th most valuable company in the world and the 1,719th biggest in South Korea. Its market cap has decreased by 12.57% in one year.
Market Cap
55.78B
Enterprise Value
35.44B
Revenue
11.28B
Global Rank
Country Rank
#1,719 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 8, 2021, GENINUS's market cap has decreased from 145.65B to 55.78B, a decrease of -61.70%. That is a compound annual growth rate of -17.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 55.78B | -52.22% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
| Nov 8, 2021 | 145.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 196.66B |
| 3billion | 167.70B |
| GC Medical Science | 86.51B |
| Inventera | 72.29B |
| Protia | 69.74B |
| HLB Panagene | 63.47B |
| Cytogen | 61.17B |
| Seoulin Bioscience | 34.05B |